This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Innovations of Shawn Erik Lillie
Introduction
Shawn Erik Lillie is an accomplished inventor based in Puyallup, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant proteins. With a total of 5 patents to his name, Lillie has demonstrated a commitment to advancing scientific knowledge and practical applications.
Latest Patents
Among his latest patents, Lillie has developed methods for increasing the mannose content of recombinant proteins. This invention relates to innovative techniques for modulating the mannose content, which is crucial for enhancing the efficacy of therapeutic proteins. His work in this area has the potential to impact various applications in medicine and biotechnology.
Career Highlights
Lillie is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.
Collaborations
Some of Lillie's notable coworkers include Jian Wu and Sean Davern. Their collaborative efforts have likely played a role in the successful development of his patents and innovations.
Conclusion
Shawn Erik Lillie's contributions to biotechnology through his patents and work at Amgen Inc. highlight his role as a significant inventor in the field. His innovative methods for increasing mannose content in recombinant proteins showcase the potential for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile